Aims There are continuing uncertainties about how much screening for type 2 diabetes
brings forward the clinical diagnosis and the impact that earlier diagnosis has on health …

Aims/hypothesis We aimed to investigate whether diabetes cases detected through
screening have better health outcomes than clinically detected cases in a population-based …

Diabet. Med. 28, 1416–1424 (2011) Abstract Aims To describe and compare attendance
rates and the proportions of people identified with Type 2 diabetes mellitus in people with …

Aims/hypothesis Trials have not demonstrated benefits to the population of screening for
type 2 diabetes. However, there may be cost savings for those found to have diabetes. We …

Background Type 2 diabetes is common, costly and often goes unrecognised for many
years. When patients are diagnosed, the majority exhibit associated tissue damage or …

Abstract Aims Screening for Type 2 diabetes has been recommended in several countries
due to the increasing prevalence of diabetes. This review evaluates whether Type 2 …

RCTs of whether screening asymptomatic individuals for undiagnosed diabetes results in
reduced mortality or has other benefits have been suggestive, but inconclusive. In this issue …

Background The increasing prevalence of type 2 diabetes poses a major public health
challenge. Population-based screening and early treatment for type 2 diabetes could reduce …

OBJECTIVE—To develop a simple self-administered questionnaire identifying individuals
with undiagnosed diabetes with a sensitivity of 75% and minimizing the high-risk group …

Summary Aims Screening for asymptomatic Type 2 diabetes mellitus has been advocated
on the grounds that diabetes is a common condition associated with increased morbidity …